NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis By Ogkologos - November 18, 2025 247 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from MyRisk study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR April is Occupational Therapy (OT) Month- What is OT and how... April 8, 2021 The American Society of Clinical Oncology and the American Cancer Society:... February 1, 2022 Rucaparib Approved as Maintenance Treatment for Some Recurrent Ovarian Cancers May 4, 2018 Georgia Middle Schooler Donates All the Proceeds of Her Grand Champion... January 7, 2021 Load more HOT NEWS TILs Therapy Shows Promise in the Management of Anti-PD-1-Resistant Metastatic NSCLC 2021 ASCO Annual Meeting: Immunotherapy for Melanoma and Non-Small Cell Lung Cancer,... Moxetumomab Approved by FDA for Hairy Cell Leukemia The Investigational PD1 Antibody, Tislelizumab, Shows Promise in Patients With Unresectable...
